APOL1 variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress
Polymorphisms in the Apolipoprotein L1 (APOL1) gene are common in ancestrally African populations, and associate with kidney injury and cardiovascular disease. These risk variants (RV) provide an advantage in resisting Trypanosoma brucei, the causal agent of African trypanosomiasis, and are largely...
Main Authors: | Ashira Blazer, Yingzhi Qian, Martin Paul Schlegel, Huda Algasas, Jill P. Buyon, Ken Cadwell, Michael Cammer, Sean P. Heffron, Feng-Xia Liang, Shilpi Mehta-Lee, Timothy Niewold, Sara E. Rasmussen, Robert M. Clancy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.769936/full |
Similar Items
-
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
by: Gizelle M. McCarthy, et al.
Published: (2021-08-01) -
Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults
by: Ogo Egbuna, et al.
Published: (2024-03-01) -
APOL1 Gene Variants and Risk for Cardiovascular Disease
by: Carlos Eduardo Duran, et al.
Published: (2023-12-01) -
3448 Macrophages, APOL1 Genotype, & Immunometabolism in CVD (MAGIC
by: Ashira D. Blazer, et al.
Published: (2019-03-01) -
APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients
by: Teresa K. Chen, et al.
Published: (2021-02-01)